Rapid Communication
Journal of Cerebral Blood Flow & Metabolism (1999) 19, 139–143; doi:10.1097/00004647-199902000-00004
Synergistic Protective Effects of Antioxidant and Nitric Oxide Synthase Inhibitor in Transient Focal Ischemia
Brigitte Spinnewyn, Sylvie Cornet, Michel Auguet and Pierre-Etienne Chabrier
Institut Henri Beaufour Research Labs, Les Ulis Cedex, France
Correspondence: Pierre-Etienne Chabrier, Institut Henri Beaufour, 5, Avenue du Canada, 91966 Les Ulis Cedex, France.
Received 4 August 1998; Revised 29 September 1998; Accepted 29 September 1998.
Abstract
Both nitric oxide synthase (NOS) inhibitors and free radical scavengers have been shown to protect brain tissue in ischemia-reperfusion injury. Nitric oxide and superoxide anion act via distinct mechanisms and react together to form the highly deleterious peroxynitrite. Therefore the authors examined the effects and the interaction between the NOS inhibitor, NG nitro-L-arginine (LNA) and the antioxidant/superoxide scavenger, di-tert-butyl-hydroxybenzoic acid (DtBHB) in the rat submitted to 2 hours of middle cerebral artery occlusion. Posttreatment was initiated 4 hours after the onset of ischemia and infarct volume was measured at 48 hours. The dose-related effect of LNA resulted in a bell-shaped curve: 15, 56, 65, and 33% reduction of total infarct for 0.03, 0.1, 0.3, and 1 mg/kg (intravenously [IV]) respectively and 11% increase in infarct volume for 3 mg/kg (IV). Whereas DtBHB (20 mg/kg; intraperitoneally [IP]) was ineffective, the dose of 60 mg/kg produced 65% protection in infarct volume. The combination of a subthreshold dose of LNA (0.03 mg/kg; IV) and DtBHB (20 mg/kg; IP) resulted in significant reduction (49%) in infarct volume. These results show that LNA and DtBHB act synergistically to provide a consistent neuroprotection against ischemic injury when administered 4 hours after ischemia. This suggests that nitric oxide and free radicals are involved and interact in synergy in ischemia-reperfusion injury.
Keywords:
Nitric oxide synthase inhibitor, Antioxidant, Cerebral ischemia, Rat
Abbreviations:
DtBHB, di-tert-butyl-hydroxybenzoic acid; IV, intravenous; LNA, NG nitro-L-arginine; MCAO, middle cerebral artery occlusion; NO, nitric oxide; NOS, nitric oxide synthase

